טוען...
Amantadine Therapy for Chronic Hepatitis C: A Randomized Double-blind Placebo-controlled Trial
OBJECTIVE: Although treatment of hepatitis C has improved, up to 50% do not respond to standard therapy with interferon regimes or cannot tolerate the treatment due to side effects. The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Science Inc
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1492374/ https://ncbi.nlm.nih.gov/pubmed/15209605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2004.30057.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|